DNA
| 2 min read
Company is first to deliver ultra-long, fully verified DNA in less than 25 days, backed by the industry’s only on-time guarantee
| 3 min read
The funding round will support expanded US manufacturing and accelerate the company’s enzymatic DNA synthesis technology.
| 2 min read
The state-of-the-art facility will deliver CGMP plasmid DNA development and manufacturing services by late 2025.
| 2 min read
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market
| 4 min read
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
| 4 min read
A new technique boosts the sensitivity of mass cytometry to allow detection and characterization of low-abundance markers, yielding new disease insights.
| 5 min read
Researchers created an improved method for assays that detect viral vectors in a patient’s blood or urine. It’s used to ensure that bystanders will not be exposed.
| 3 min read
Nuclear structures that facilitate DNA repair could lead to new cancer therapies.
| 4 min read
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects.
Available on Demand
Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.
